Diranersen misses study's main goal but shows signs of cognitive benefit ...

What comes after trastuzumab deruxtecan?

Another wave of layoffs has hit one of the Bay Area's biggest biotech companies—and the latest cuts push a troubling trend ...

UB-led team has found a way to use AI to reveal these otherwise invisible cortical lesions by reviewing existing MRI scans.

A month after Genentech confirmed the restructuring of its early development group, the Roche subsidiary has now disclosed ...

Learn about notable updates that occurred in June 2026 for investigational products in development (not an inclusive list).

Biotech pioneer Genentech will cut 103 jobs in its latest round of layoffs, including its head of cell therapy and 33 ...

Genentech has launched another round of workforce reductions affecting more than 100 employees as the Roche subsidiary ...

Genentech will cut 103 jobs across several areas of the company at its South San Francisco headquarters, including its ...

Five oral presentations in a Featured Research Session will highlight trontinemab, including new long-term data from Phase Ib/IIa Brainshuttle AD study and design of Phase III PrevenTRON study in ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today positive results from the Phase III Krascendo 1 study evaluating divarasib, an investigational next-generation KRAS ...

Astex Pharmaceuticals on Cambridge Science Park has tapped into a gold mine through a mega-deal with Genentech, a member of ...